Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
18.37
+1.27 (7.43%)
Oct 11, 2024, 4:00 PM EDT - Market closed
Arcus Biosciences Employees
Arcus Biosciences had 577 employees as of December 31, 2023. The number of employees increased by 77 or 15.40% compared to the previous year.
Employees
577
Change (1Y)
77
Growth (1Y)
15.40%
Revenue / Employee
$428,076
Profits / Employee
-$431,542
Market Cap
1.68B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Fortrea Holdings | 18,000 |
Teladoc Health | 5,600 |
NeoGenomics | 2,100 |
NovoCure | 1,453 |
GeneDx Holdings | 1,000 |
CareDx | 643 |
MannKind | 414 |
Syndax Pharmaceuticals | 184 |
RCUS News
- 2 days ago - Arcus Biosciences Announces New Employment Inducement Grants - Business Wire
- 3 days ago - Arcus Biosciences to Present First Clinical Data from ARC-20 Study at the 2024 EORTC-NCI-AACR Symposium - Business Wire
- 9 days ago - Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma - Business Wire
- 19 days ago - Arcus Biosciences Looks Compelling Ahead Of Key Clinical Oncology Milestones - Seeking Alpha
- 6 weeks ago - Arcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital - Business Wire
- 7 weeks ago - Arcus Biosciences to Participate in Two Upcoming Investor Conferences - Business Wire
- 2 months ago - Arcus Biosciences: Getting Too Cheap To Ignore (Reiterate Buy) - Seeking Alpha
- 2 months ago - Arcus Biosciences, Inc. (RCUS) Q2 2024 Earnings Call Transcript - Seeking Alpha